Guardion Competitors

Delisted . USA . 
Stock . Guardion Health Sciences
Guardion Health Sciences competes with Biofrontera, Shuttle Pharmaceuticals, Akanda Corp, China Pharma, and Alpha Teknova; as well as few others. The company conducts business under Personal Care Products sector and is part of Consumer Staples industry. Analyzing Guardion Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Guardion Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Guardion Health competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardion Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details

Guardion Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Guardion Health and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Guardion and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Guardion Health Sciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
PTPI
+ 0.77
SHPH
TKNO
+ 0.71
BFRI
PTPI
+ 0.71
TKNO
TKNO
+ 0.7
SHPH
CYTH
+ 0.65
AKAN
LFCR
+ 0.57
PTPI
  
High negative correlations   
LFCR
- 0.71
CYTH
ORGO
- 0.69
TKNO
ORGO
- 0.67
BFRI
ORGO
- 0.65
PTPI
ORGO
- 0.65
SHPH
LFCR
- 0.57
AKAN

Risk-Adjusted Indicators

There is a big difference between Guardion Pink Sheet performing well and Guardion Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Guardion Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BFRI  3.17  0.15  0.00 (0.02) 0.00 
 0.00 
 6.36 
(7.27)
 26.22 
SHPH  4.40 (0.63) 0.00 (0.66) 0.00 
 0.00 
 11.36 
(8.33)
 25.23 
AKAN  3.38  0.26  0.04  0.02  4.08 
(3.76)
 8.28 
(6.13)
 25.81 
CPHI  6.56  0.62  0.11 (0.50) 6.69 
(10.28)
 19.05 
(14.29)
 45.32 
AGRX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
TKNO  4.18 (0.24) 0.00 (0.26) 0.00 
 0.00 
 7.17 
(8.22)
 24.03 
CYTH  4.79  0.46  0.11 (0.86) 5.31 
(6.88)
 10.29 
(10.14)
 76.39 
PTPI  8.35 (1.69) 0.00  0.20  0.00 
 0.00 
 14.29 
(18.18)
 136.91 
LFCR  2.89 (0.05) 0.00 (0.28) 0.00 
 0.00 
 6.59 
(7.10)
 28.39 
ORGO  5.11  1.96  0.28  0.21  3.93 
(6.65)
 6.74 
(7.34)
 115.16 
All Fundamental Data

Guardion Health Competitive Analysis

The better you understand Guardion Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Guardion Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Guardion Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BFRI SHPH AKAN CPHI TKNO CYTH PTPI LFCR ORGO AQST
 1.06 
 0.93 
Biofrontera
 13.95 
 0.37 
Shuttle
 0.68 
 1.45 
Akanda
 7.69 
 0.24 
China
 7.31 
 5.58 
Alpha
 4.48 
 0.70 
Cyclo
 0.71 
 0.08 
Petros
 1.73 
 6.47 
Lifecore
 4.57 
 5.01 
Organogenesis
 4.41 
 2.84 
Aquestive
Market Volatility
(90 Days Market Risk)
Unstable
Out of control
Dangerous
Out of control
Moderately volatile
Out of control
Out of control
Slightly risky
Dangerous
Relatively risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Insignificant
OK
Very Weak
Modest
Very Weak
Very Weak
Modest
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Very High
Very High
Very High
Above Average
Below Average
Above Average
Very High
Above Average
Very Low
Above Average
Current Valuation
(Equity Enterprise Value)
Under Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Buy
Not Available
Not Available
Not Available
Strong Buy
Buy
Buy
Buy
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Hold
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Hold
Strong Hold
Strong Sell
Current Ratio
3.16
0.03
0.48
0.75
6.76
2.93
3.1
N/A
2.62
1.47
Net Asset
27.93 M
2.51 B
8.84 M
16.47 M
118.77 M
13.25 M
33.8 M
273.7 M
497.89 M
101.42 M
Profit Margin
-0.36
N/A
N/A
-0.7
-0.71
N/A
-1.18
-0.11
0.0018
-0.77
EBITDA
(18.45 M)
(7.7 B)
(27.74 M)
8.44 K
(26.15 M)
(20.03 M)
(4.21 M)
35.6 M
(1.28 M)
(26.62 M)
Operating Margin
-0.55
N/A
-4.93
-1.5
-0.61
-35.46
-1.48
-0.0478
0.0807
-1.14
Current Valuation
6.28 M
1.39 M
(3.57 M)
8.36 M
277.65 M
34.19 M
5.5 M
359.96 M
697.28 M
257.14 M
Price To Book
1.48
3.02
0.45
0.78
3.37
59.1
0.69
15.41
2.54
N/A
Retained Earnings
(99.65 M)
(34.58 B)
(53.36 M)
(39.29 M)
(118.53 M)
(83.86 M)
(98.89 M)
(166.52 M)
(40.11 M)
(363.21 M)
Current Asset
N/A
N/A
N/A
20.99 M
N/A
N/A
N/A
N/A
24.47 M
38.38 M
Beta
0.31
0.29
1.61
0.71
0.42
-0.57
2.03
0.97
1.66
2.76
Number Of Employees
83
9
N/A
231
N/A
8
21
524
869
142
Shares Outstanding
8.87 M
4.92 M
1.43 M
19.25 M
53.44 M
32.74 M
25.27 M
37.03 M
126.83 M
98.87 M
Cash Flow From Operations
(24.89 M)
(7.33 B)
(1.5 M)
(699.69 K)
(12.39 M)
(16.19 M)
(7.63 M)
(217 K)
14.21 M
(35.76 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
5.4 M
1.65 B
4 M
4.63 M
20.73 M
1.03 M
8.28 M
130.36 M
43.31 M
38 M
Return On Equity
-3.91
-3.84
-2.43
-0.75
-0.31
-226.64
-0.93
-0.3
0.0026
N/A
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.46
-1.14
-0.26
-0.18
-0.13
-2.84
-0.28
-0.0247
0.0281
-0.24
Number Of Shares Shorted
165.54 K
25.66 K
47.37 K
93.6 K
964.01 K
736.31 K
2.1 M
2.4 M
8.67 M
9.98 M
Book Value Per Share
0.85
0.17
3.52
0.7
1.54
-0.47
0.31
0.42
2.09
-0.66
Current Liabilities
N/A
N/A
N/A
12.95 M
N/A
N/A
N/A
N/A
23.22 M
17.95 M
Total Asset
27.93 M
2.51 B
8.84 M
16.47 M
118.77 M
13.25 M
33.8 M
273.7 M
497.89 M
101.42 M
Short Ratio
0.54
0.78
0.41
0.22
5.95
0.14
0.03
19.93
2.9
4.93
Target Price
11.5
N/A
N/A
3.0
11.0
0.95
1.0
10.0
6.0
9.86
Debt To Equity
N/A
0.091
0.027
2.63
0.27
N/A
0.31
N/A
0.52
468.2
Shares Owned By Institutions
36.4
9.42
1.34
0.21
82.67
11.45
10.28
73.59
49.75
48.31
Market Capitalization
8.34 M
2.1 M
2.08 M
3.69 M
277.87 M
22.92 M
2.15 M
235.48 M
665.85 M
268.93 M
Price To Earning
N/A
N/A
N/A
-0.89
N/A
N/A
N/A
N/A
17.12
-1.9
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3.51
6.15
N/A
Price To Sales
0.24
N/A
0.83
0.91
7.36
26.32
0.53
1.8
1.38
4.67
Net Income
(20.13 M)
(9.14 M)
(32.28 M)
(3.08 M)
(26.75 M)
(20.06 M)
(8.16 M)
9.33 M
861 K
(44.14 M)
Earnings Per Share
1.16
-3.3
-524.76
-0.69
-0.57
-0.9
-3.8
-0.56
-0.01
-0.51
Shares Owned By Insiders
20.71
27.98
1.65
51.28
9.27
48.45
6.81
4.52
46.65
4.47
Revenue
34.07 M
N/A
2.16 M
7.01 M
37.74 M
1.08 M
5.82 M
128.26 M
482.04 M
57.56 M
Working Capital
4.99 M
677.15 K
(8.37 M)
(823.73 K)
31.57 M
3.85 M
9.62 M
42.16 M
208.46 M
69.36 M
Cash And Equivalents
31.91 M
50.44 K
N/A
2.24 M
64.73 M
4.29 M
13.3 M
N/A
113.24 M
17.7 M
Cash Per Share
1.36
N/A
N/A
0.04
2.3
0.51
0.64
N/A
0.87
0.33
Gross Profit
16.66 M
N/A
259.56 K
349.27 K
7.23 M
794.48 K
2.92 M
45.64 M
366.3 M
39.69 M
Day Typical Price
0.92
0.37
1.45
0.25
5.48
0.7
0.0844
6.43
5.13
2.83
Accumulation Distribution
3556.29
247524.0
595.71
34065.54
9919.76
0.0959
329926.0
0.017
78876.18
43675.6
Market Facilitation Index
0.0
N/A
0.0
N/A
0.0
0.07
N/A
0.11
N/A
N/A
Daily Balance Of Power
(0.14)
(1.00)
(0.14)
(1.00)
1.0
0.4286
(0.1)
1.0
(0.59)
0.8
Period Momentum Indicator
(0.01)
(0.06)
(0.01)
(0.02)
0.38
0.03
(0.0006)
0.11
(0.24)
0.12
Rate Of Daily Change
0.99
0.86
0.99
0.92
1.07
1.04
0.99
1.02
0.95
1.04
Day Median Price
0.92
0.37
1.44
0.25
5.43
0.7
0.0844
6.42
5.2
2.83
Price Action Indicator
0.01
(0.03)
N/A
(0.02)
0.34
0.02
(0.0003)
0.11
(0.31)
0.075
Coefficient Of Variation
(35,310)
(697.25)
11345.64
1041.83
(1,032)
1564.14
(1,534)
(4,291)
1155.1
(703.28)
Mean Deviation
3.17
4.4
3.38
6.56
4.18
4.79
8.35
2.89
5.11
3.17
Jensen Alpha
0.1491
(0.63)
0.2595
0.6177
(0.24)
0.4601
(1.69)
(0.05)
1.96
(0.50)
Total Risk Alpha
0.7229
0.1279
0.8003
2.4
0.3591
2.03
1.55
0.6001
3.43
0.1028
Sortino Ratio
N/A
N/A
0.0384
0.1077
N/A
0.11
N/A
N/A
0.2774
N/A
Downside Variance
N/A
N/A
20.16
87.15
N/A
39.76
N/A
N/A
22.0
N/A
Standard Deviation
4.42
5.5
4.57
9.1
5.15
8.78
15.08
4.2
13.5
4.28
Kurtosis
1.55
0.0065
1.65
0.9788
0.0646
22.11
17.5
3.34
49.98
1.82
Potential Upside
6.36
11.36
8.28
19.05
7.17
10.29
14.29
6.59
6.74
6.23
Treynor Ratio
(0.02)
(0.66)
0.0188
(0.50)
(0.26)
(0.86)
0.2031
(0.28)
0.2063
(0.72)
Maximum Drawdown
26.22
25.23
25.81
45.32
24.03
76.39
136.91
28.39
115.16
21.67
Variance
19.57
30.22
20.88
82.79
26.57
77.05
227.39
17.65
182.37
18.36
Market Risk Adjusted Performance
(0.01)
(0.65)
0.0288
(0.49)
(0.25)
(0.85)
0.2131
(0.27)
0.2163
(0.71)
Risk Adjusted Performance
0.0057
(0.11)
0.0156
0.0901
(0.07)
0.063
(0.05)
(0.01)
0.0825
(0.11)
Skewness
0.1758
0.5206
0.621
0.5207
0.3828
3.44
2.26
(0.14)
6.65
0.8185
Semi Deviation
N/A
N/A
4.08
6.69
N/A
5.31
N/A
N/A
3.93
N/A
Information Ratio
0.0271
(0.12)
0.0378
0.1105
(0.07)
0.079
(0.06)
0.0082
0.0964
(0.11)
Value At Risk
(7.27)
(8.33)
(6.13)
(14.29)
(8.22)
(10.14)
(18.18)
(7.10)
(7.34)
(7.48)
Expected Short fall
N/A
N/A
(3.76)
(10.28)
N/A
(6.88)
N/A
N/A
(6.65)
N/A
Downside Deviation
N/A
N/A
4.49
9.34
N/A
6.31
N/A
N/A
4.69
N/A
Semi Variance
N/A
N/A
16.66
44.75
N/A
28.25
N/A
N/A
15.42
N/A

Guardion Health Competition Performance Charts

Five steps to successful analysis of Guardion Health Competition

Guardion Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Guardion Health Sciences in relation to its competition. Guardion Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Guardion Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Guardion Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Guardion Health Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Guardion Health position

In addition to having Guardion Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities ETFs Thematic Idea Now

Utilities ETFs
Utilities ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Utilities ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Guardion Pink Sheet

If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY